Kahraman et al. examined the hepatic fetuin-A expression in 108 morbidly obese NAFLD patients (50 with NASH and 58 with SS) undergoing bariatric surgery. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.